Article Information
History
- December 21, 2020.
Article Versions
- Version 1 (December 14, 2020 - 18:20).
- Version 2 (December 15, 2020 - 02:51).
- You are currently viewing Version 3 of this article (December 21, 2020 - 22:50).
- Version 4 (January 14, 2021 - 06:12).
- Version 5 (February 9, 2021 - 15:42).
- View Version 6, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- SA Kemp1,2,3,
- WT Harvey4,
- RP Datir2,
- DA Collier1,2,3,
- IATM Ferreira2,3,
- AM Carabelli3,
- DL Robertson4,5 and
- RK Gupta2,3,*
- 1Division of Infection and Immunity, University College London, London, UK.
- 2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
- 3Department of Medicine, University of Cambridge, Cambridge, UK.
- 4MRC - University of Glasgow Centre for Virus Research, Glasgow, UK.
- 5Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK
- ↵*Address for correspondence: Ravindra K. Gupta, Cambridge Institute for Therapeutic Immunology and Infectious Diseases Jeffrey Cheah Biomedical Centre, Puddicombe Way Cambridge CB2 0AW, UK Tel: +44 1223 331491, rkg20{at}cam.ac.uk